CDC42 and breast carcinoma: Recently, Sayedyahossein et al48 reported identification of small molecules that disrupt binding of Cdc42 and IQGAP1 and inhibit proliferation and migration of breast carcinoma cells lending further credence to the approach of targeting the GRD domain of IQGAP1.